GeneCellNano Flagship

The GeneCellNano program was selected as an Academy of Finland Flagship. The idea behind the flagship is to make progress in the treatment of important diseases using advanced biologic technologies.
Target diseases include ischemic heart disease, selected cancers, and retinopathy. The application was spearheaded by Seppo Ylä-Herttuala from the University of Eastern Finland and Seppo Vainio from the University of Oulu. In addition to groups from these two universities, the consortium features also groups from Aalto University (Olli Ikkala) and the University of Helsinki (groups Marjo Yliperttula, Timo Laaksonen, Hélder A. Santos, Tatu Lajunen, and my own).

Link to the Academy of Finland press release: https://www.aka.fi/en/about-us/whats-new/press-releases/20202/academy-of...